NCT07718373

Brief Summary

Acute kidney injury (AKI) is common after cardiac surgery, yet effective protective strategies remain limited. L-arginine is the substrate for endogenous nitric oxide (NO) synthesis and may improve renal perfusion and endothelial function. investigators emulated a target trial to evaluate whether early perioperative L-arginine was associated with a lower risk of AKI after cardiac surgery.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jul 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jul 2026Aug 2026

First Submitted

Initial submission to the registry

July 14, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

July 20, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2026

Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

July 14, 2026

Last Update Submit

July 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Acute kidney injury

    defined by KDIGO criteria

    within 7 postoperative days

Secondary Outcomes (2)

  • Acute kidney injury stage

    within 7 postoperative days

  • in-hospital mortality.

    up to 48 weeks

Study Arms (2)

L-arginine

Initiation of L-arginine within 3 postoperative days

Drug: L-arginine

No L-arginine

No L-arginine therapy within 3 postoperative days

Interventions

Initiation of L-arginine within 3 postoperative days

L-arginine

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adults admitted to the ICU after CPB-assisted cardiac surgery

You may qualify if:

  • ·adults admitted to the ICU after CPB-assisted cardiac surgery

You may not qualify if:

  • congenital heart disease,
  • surgery requiring deep hypothermic circulatory arrest,
  • a preoperative baseline estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m²,
  • AKI already present prior to ICU admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Lei C, Berra L, Rezoagli E, Yu B, Dong H, Yu S, Hou L, Chen M, Chen W, Wang H, Zheng Q, Shen J, Jin Z, Chen T, Zhao R, Christie E, Sabbisetti VS, Nordio F, Bonventre JV, Xiong L, Zapol WM. Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery. Am J Respir Crit Care Med. 2018 Nov 15;198(10):1279-1287. doi: 10.1164/rccm.201710-2150OC.

    PMID: 29932345BACKGROUND
  • Landoni G, Monaco F, Ti LK, Baiardo Redaelli M, Bradic N, Comis M, Kotani Y, Brambillasca C, Garofalo E, Scandroglio AM, Viscido C, Paternoster G, Franco A, Porta S, Ferrod F, Calabro MG, Pisano A, Vendramin I, Barucco G, Federici F, Severi L, Belletti A, Cortegiani A, Bruni A, Galbiati C, Covino A, Baryshnikova E, Giardina G, Venditto M, Kroeller D, Nakhnoukh C, Mantovani L, Silvetti S, Licheri M, Guarracino F, Lobreglio R, Di Prima AL, Fresilli S, Labanca R, Mucchetti M, Lembo R, Losiggio R, Bove T, Ranucci M, Fominskiy E, Longhini F, Zangrillo A, Bellomo R; PROTECTION Study Group. A Randomized Trial of Intravenous Amino Acids for Kidney Protection. N Engl J Med. 2024 Aug 22;391(8):687-698. doi: 10.1056/NEJMoa2403769. Epub 2024 Jun 12.

    PMID: 38865168BACKGROUND

MeSH Terms

Conditions

Acute Kidney Injury

Interventions

Arginine

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Amino Acids, BasicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, DiaminoAmino Acids, Essential

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, Head of Anesthesia Clinical Research Center, Xijing Hospital

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 22, 2026

Study Start

July 20, 2026

Primary Completion (Estimated)

August 20, 2026

Study Completion (Estimated)

August 20, 2026

Last Updated

July 22, 2026

Record last verified: 2026-07